Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins

Proteomics

Volumn 12, Issue 13, 2012, Pages 2139-2148

  Lund, Rikke Raaen ^a   Terp, Mikkel Green ^a   Lænkholm, Anne Vibeke ^b   Jensen, Ole Nørregaard ^a   Leth Larsen, Rikke ^a   Ditzel, Henrik Jørn ^a,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b SLAGELSE HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biomarkers; Biomedicine; Cancer tissue; Mass spectrometry; Metastasis; Myosin 9

Indexed keywords

LACTATE DEHYDROGENASE; MYOSIN IIA; PROTEOME; STABLE ISOTOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BREAST CANCER; CONTROLLED STUDY; HISTOGENESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTOPE LABELING; MICE; MICE, SCID; MYOSINS; NEOPLASM METASTASIS; NEOPLASMS; PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

MUS;

EID: 84864017230     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100490     Document Type: Article

References (33)

1. Leth-Larsen, R., Lund, R. R., Ditzel, H. J., Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol. Cell Proteomics 2010, 9, 1369-1382.
2. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
3. Lacroix, M., Toillon, R. A., Leclercq, G., Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr. Relat Cancer 2004, 11, 497-522.
4. Nguyen, D. X., Bos, P. D., Massague, J., Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9, 274-284.
5. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R. et al., Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat. Methods 2010, 7, 383-385.
6. Urquidi, V., Sloan, D., Kawai, K., Agarwal, D. et al., Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 2002, 8, 61-74.
7. Goodison, S., Kawai, K., Hihara, J., Jiang, P. et al., Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res. 2003, 9, 3808-3814.
8. Montel, V., Huang, T. Y., Mose, E., Pestonjamasp, K. et al., Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am. J. Pathol. 2005, 166, 1565-1579.
9. Goodison, S., Viars, C., Urquidi, V., Molecular cytogenetic analysis of a human breast metastasis model: identification of phenotype-specific chromosomal rearrangements. Cancer Genet. Cytogenet. 2005, 156, 37-48.
10. Suzuki, M., Mose, E. S., Montel, V., Tarin, D., Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am. J. Pathol. 2006, 169, 673-681.
11. Schwirzke, M., Evtimova, V., Burtscher, H., Jarsch, M. et al., Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines. Anticancer Res. 2001, 21, 1771-1776.
12. Euer, N., Schwirzke, M., Evtimova, V., Burtscher, H. et al., Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res. 2002, 22, 733-740.
13. Goodison, S., Yuan, J., Sloan, D., Kim, R. et al., The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 2005, 65, 6042-6053.
14. Lund, R., Leth-Larsen, R., Jensen, O. N., Ditzel, H. J., Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. J. Proteome Res. 2009, 8, 3078-3090.
15. Leth-Larsen, R., Lund, R., Hansen, H. V., Laenkholm, A. V. et al., Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol. Cell Proteomics 2009, 8, 1436-1449.
16. Kreunin, P., Yoo, C., Urquidi, V., Lubman, D. M. et al., Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry. Cancer Genom. Proteomics 2007, 4, 329-339.
17. Kreunin, P., Urquidi, V., Lubman, D. M., Goodison, S., Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique. Proteomics 2004, 4, 2754-2765.
18. Kreunin, P., Yoo, C., Urquidi, V., Lubman, D. M. et al., Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 2007, 7, 299-312.
19. Montel, V., Mose, E. S., Tarin, D., Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int. J. Cancer 2006, 119, 251-263.
20. Rappsilber, J., Ishihama, Y., Mann, M., Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003, 75, 663-670.
21. Callesen, A. K., Mohammed, S., Bunkenborg, J., Kruse, T. A. et al., Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom 2005, 19, 1578-1586.
22. Schandorff, S., Olsen, J. V., Bunkenborg, J., Blagoev, B. et al., A mass spectrometry-friendly database for cSNP identification. Nat. Methods 2007, 4, 465-466.
23. Elias, J. E., Gibbons, F. D., King, O. D., Roth, F. P. et al., Intensity-based protein identification by machine learning from a library of tandem mass spectra. Nat. Biotechnol. 2004, 22, 214-219.
24. Mortensen, P., Gouw, J. W., Olsen, J. V., Ong, S. E. et al., MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J. Proteome Res. 2010, 9, 393-403.
25. Ham, B. M., Yang, F., Jayachandran, H., Jaitly, N. et al., The influence of sample preparation and replicate analyses on HeLa cell phosphoproteome coverage. J. Proteome Res. 2008, 7, 2215-2221.
26. Kulasingam, V., Diamandis, E. P., Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell Proteomics 2007, 6, 1997-2011.
27. Vicente-Manzanares, M., Ma, X., Adelstein, R. S., Horwitz, A. R., Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 2009, 10, 778-790.
28. Kaelin, W. G., Jr., Thompson, C. B., Q&A: cancer clues from cell metabolism. Nature 2010, 465, 562-564.
29. Kim, H. K., Park, W. S., Kang, S. H., Warda, M. et al., Mitochondrial alterations in human gastric carcinoma cell line. Am. J. Physiol. Cell Physiol. 2007, 293, C761-C771.
30. Rae, J., Creighton, C., Meck, J., Haddad, B. et al., MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treatment 2007, 104, 13-19.
31. Chambers, A. F., MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res. 2009, 69, 5292-5293.
32. Sellappan, S., Grijalva, R., Zhou, X., Yang, W. et al., Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res. 2004, 64, 3479-3485.
33. Montel, V., Suzuki, M., Galloy, C., Mose, E. S. et al., Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation 2009, 78, 283-291.